All In Biotech

Drug Trial Radar · NCT03354598

Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women

A Prospective Phase 3 Randomized Multi-center Double-blind Study of Efficacy Tolerability & Safety of Oral Sulopenem-etzadroxil/Probenecid vs Ciprofloxacin for Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women

Last checked: Nov 19, 2026Latest source record: Jan 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,671 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,671

Actual

Start

Aug 1, 2018

Primary completion

Jan 16, 2020

Study completion Jan 20, 2020

Sponsor

Sponsor type
Industry
First posted
Nov 28, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy, tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin for treatment of uncomplicated urinary tract infection (uUTI) in adult women

Conditions

  • Uncomplicated Urinary Tract Infections

Interventions

  • Sulopenem-Etzadroxil/ProbenecidDrug

    Treatment of uncomplicated urinary tract infection

  • CiprofloxacinDrug

    Treatment of uncomplicated urinary tract infection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants With Overall SuccessTime frame: Day 12+/-1 day
  2. Percentage of Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants With Overall SuccessTime frame: Day 12 +/- 1 day

Locations

60 sites in 1 country. Site status is shown where the registry gives one.

  • Medical Facility

    Birmingham, Alabama

  • Medical Facility

    Phoenix, Arizona

  • Medical Facility

    Tolleson, Arizona

  • Medical Facility

    Cerritos, California

  • Medical Facility

    Chula Vista, California

  • Medical Facility

    Fullerton, California

  • Medical Facility

    La Mesa, California

  • Medical Facility

    Los Angeles, California

  • Medical Facility

    San Diego, California

  • Medical Facility

    Sylmar, California

  • Medical Facility

    Washington D.C., District of Columbia

  • Medical Facility

    Bradenton, Florida

  • Medical Facility

    Clearwater, Florida

  • Medical Facility

    Doral, Florida

  • Medical Facility

    Edgewater, Florida

  • Medical Facility

    Hialeah, Florida

  • Medical Facility

    Lauderdale Lakes, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami, Florida

  • Medical Facility

    Miami Springs, Florida

  • Medical Facility

    New Port Richey, Florida

  • Medical Facility

    Ormond Beach, Florida

  • Medical Facility

    Palmetto Bay, Florida

  • Medical Facility

    St. Petersburg, Florida

  • Medical Facility

    Winter Haven, Florida

  • Medical Facility

    Atlanta, Georgia

  • Medical Facility

    Norcross, Georgia

  • Medical Facility

    Perry, Georgia

  • Medical Facility

    Lake Charles, Louisiana

  • Medical Facility

    Metairie, Louisiana

  • Medical Facility

    New Orleans, Louisiana

  • Medical Facility

    Las Vegas, Nevada

  • Medical Facility

    Las Vegas, Nevada

  • Medical Facility

    Brooklyn, New York

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.